首页 | 本学科首页   官方微博 | 高级检索  
     

小剂量反应停联合地塞米松治疗老年多发性骨髓瘤临床疗效分析
引用本文:徐城林. 小剂量反应停联合地塞米松治疗老年多发性骨髓瘤临床疗效分析[J]. 四川省卫生管理干部学院学报, 2008, 27(3)
作者姓名:徐城林
作者单位:攀枝花市第二人民医院血液科,四川,攀枝花,617068
摘    要:目的:探讨小剂量反应停联合地塞米松治疗初治多发性骨髓瘤(mulitiple myeloma,MM)的疗效和不良反应。方法:17例治疗组患者予小剂量反应停(100mg/d起,每周增加50mg/d,2周后增至200mg/d),同时联合地塞米松40mg/d(d1~4,9~12,17~20)1个月1疗程,至少3个月。与前期给予2个疗程标准VAD方案治疗的18例患者进行历史对照。结果:治疗组与对照组相比较总有效率差异无统计学意义(P>0.05),但不良反应发生率明显小于对照组。结论:小剂量反应停联合地塞米松作为初治50岁以上MM患者的治疗方案是安全有效的。

关 键 词:小剂量反应停  地塞米松  多发性骨髓瘤

Evaluating the Therapeutic Effect on Old Patients with Multiple Myeloma of Thalidomide and Dexamethasone in Low Dose
Xu Chenglin. Evaluating the Therapeutic Effect on Old Patients with Multiple Myeloma of Thalidomide and Dexamethasone in Low Dose[J]. Journal of Sichuan Continuing Education College of Medical Sciences, 2008, 27(3)
Authors:Xu Chenglin
Affiliation:Xu Chenglin Department of Hematology; the Second People s Hospital of Panzhihua City; Panzhihua 617068; China.;
Abstract:Objective:To evaluate the therapeutic effect on old patients with multiple myeloma of thalidomide and dexamethasone in low dose and its side effect.Methods: 17 cases of treatment group are treated with thalidomide and dexamethasone for no less than three months,and compared with the 18 cases of control group treated with two courses of standard VAD protocol.Results: There has no significant difference of effective rate between this two groups(P>0.05),but the incidence rate of side effect in treatment gro...
Keywords:Thalidomide in Low Dose  Dexamethasone  Multiple Myeloma.
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号